نتائج البحث

BNIP3+ fibroblasts associated with hypoxia and inflammation predict prognosis and immunotherapy response in pancreatic ductal adenocarcinoma.

• Authors : Gao, Bo¹ (AUTHOR); Hu, Guohua¹ (AUTHOR); Sun, Boshi² (AUTHOR)

• Source: Journal of Translational Medicine. 10/14/2024, Vol. 22 Issue 1, p1-22. 22p.

تفاصيل العنوان

Redox proteomics of PANC-1 cells reveals the significance of HIF-1 signaling protein oxidation in pancreatic ductal adenocarcinoma pathogenesis.

• Authors : Tan, Chaochao^1,2 (AUTHOR); Chen, Lichun³ (AUTHOR); Guan, Xiaoyu³ (AUTHOR)

• Source: Journal of Translational Medicine. 3/16/2024, Vol. 22 Issue 1, p1-16. 16p.

تفاصيل العنوان

Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population.

• Authors : Sini, Maria Cristina¹ (AUTHOR); Doro, Maria Grazia¹ (AUTHOR); Frogheri, Laura¹ (AUTHOR)

• Source: Journal of Translational Medicine. 1/27/2024, Vol. 22 Issue 1, p1-13. 13p.

تفاصيل العنوان

TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma.

• Authors : Zhou, Yiran^1,2,3,4 (AUTHOR); Jin, Jiabin^1,2,3,4 (AUTHOR); Ji, Yuchen^1,2,3,4 (AUTHOR)

• Source: Journal of Translational Medicine. 11/30/2023, Vol. 21 Issue 1, p1-15. 15p.

تفاصيل العنوان

A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma.

• Authors : Busato, Davide^1,2 (AUTHOR); Capolla, Sara¹ (AUTHOR); Durigutto, Paolo² (AUTHOR)

• Source: Journal of Translational Medicine. 11/29/2023, Vol. 21 Issue 1, p1-13. 13p.

تفاصيل العنوان

LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability.

• Authors : Han, Lijie^1,2,3 (AUTHOR); Jiang, Yongsheng^1,2,3 (AUTHOR); Shi, Minmin^1,2,3 (AUTHOR)

• Source: Journal of Translational Medicine. 11/21/2023, Vol. 21 Issue 1, p1-21. 21p.

تفاصيل العنوان

Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer.

• Authors : Agostini, Antonio^1,2 (AUTHOR); Guerriero, Ilaria³ (AUTHOR); Piro, Geny^1,2 (AUTHOR)

• Source: Journal of Translational Medicine. 11/23/2023, Vol. 21 Issue 1, p1-15. 15p.

تفاصيل العنوان

High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to first-line nab-paclitaxel plus S-1: prospective study.

• Authors : Huang, Lei; Lv, Yao; Guan, Shasha

Subjects: CIRCULATING tumor DNA; SOMATIC mutation; PANCREATIC tumors

• Source: Journal of Translational Medicine; 2/20/2024, Vol. 22 Issue 1, p1-23, 23p

تفاصيل العنوان

Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer.

• Authors : Yang, Wenbo; Chen, Hongze; Li, Guanqun

Subjects: IMMUNOREGULATION; PANCREATIC cancer; TUMOR growth

• Source: Journal of Translational Medicine; 12/11/2023, Vol. 21 Issue 1, p1-16, 16p

تفاصيل العنوان

Immunization with a multi-antigen targeted DNA vaccine eliminates chemoresistant pancreatic cancer by disrupting tumor-stromal cell crosstalk.

• Authors : Qin, Hongquan; Chen, Jiali; Bouchekioua-Bouzaghou, Katia

Subjects: DNA vaccines; PANCREATIC tumors; PANCREATIC cancer

• Source: Journal of Translational Medicine; 11/22/2023, Vol. 21 Issue 1, p1-22, 22p

تفاصيل العنوان